4//SEC Filing
Murali Ramachandran 4
Accession 0001493152-25-025224
CIK 0001962011other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 6:50 PM ET
Size
5.1 KB
Accession
0001493152-25-025224
Insider Transaction Report
Form 4
Murali Ramachandran
VP of Research and Development
Transactions
- Award
COMMON STOCK
2025-10-08+152,672→ 299,529 total
Footnotes (2)
- [F1]Represents 152,672 restricted stock units ("RSUs") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan. The 152,672 RSUs are scheduled to vest in full on the first anniversary of the grant date.
- [F2]Consists of (1) 142,191 shares of common stock and (2) 157,338 RSUs which remain subject to vesting.
Documents
Issuer
Kairos Pharma, LTD.
CIK 0001962011
Entity typeother
Related Parties
1- filerCIK 0001870016
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 6:50 PM ET
- Size
- 5.1 KB